Cargando…

Ex vivo expanded patient-derived γδ T-cell immunotherapy enhances neuroblastoma tumor regression in a murine model

An effective therapy regimen for relapsed/refractory high-risk neuroblastoma (NB) includes the anti-GD2 monoclonal antibody, dinutuximab, in combination with temozolomide and irinotecan, supporting a role for chemo-immunotherapy in NB. γδ T cells are an attractive anti-tumor immunotherapy because of...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zoine, Jaquelyn T., Knight, Kristopher A., Fleischer, Lauren C., Sutton, Kathryn S., Goldsmith, Kelly C., Doering, Christopher B., Spencer, H. Trent
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Taylor & Francis 2019
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6682349/ https://www.ncbi.nlm.nih.gov/pubmed/31413905 http://dx.doi.org/10.1080/2162402X.2019.1593804

Ejemplares similares

Characterization of Donor Variability for γδ T Cell ex vivo Expansion and Development of an Allogeneic γδ T Cell Immunotherapy
por: Burnham, Rebecca E., et al.
Publicado: (2020)

Dissecting the cellular components of ex vivo γδ T cell expansions to optimize selection of potent cell therapy donors for neuroblastoma immunotherapy trials
por: Jonus, Hunter C., et al.
Publicado: (2022)

Non-genotoxic conditioning facilitates hematopoietic stem cell gene therapy for hemophilia A using bioengineered factor VIII
por: Russell, Athena L., et al.
Publicado: (2021)

Enhancing the effectiveness of γδ T cells by mRNA transfection of chimeric antigen receptors or bispecific T cell engagers
por: Becker, Scott A., et al.
Publicado: (2023)

Non-signaling Chimeric Antigen Receptors Enhance Antigen-Directed Killing by γδ T Cells in Contrast to αβ T Cells
por: Fleischer, Lauren C., et al.
Publicado: (2020)

γδ T Cells for Leukemia Immunotherapy: New and Expanding Trends
por: Barros, Mateus de Souza, et al.
Publicado: (2021)

CMV-Independent Lysis of Glioblastoma by Ex Vivo Expanded/Activated Vδ1+ γδ T Cells
por: Knight, Andrea, et al.
Publicado: (2013)

Therapeutic Potential of Ex Vivo Expanded γδ T Cells against Osteosarcoma Cells
por: Ko, Yunmi, et al.
Publicado: (2022)

Identification and targeting of protein tyrosine kinase 7 (PTK7) as an immunotherapy candidate for neuroblastoma
por: Lee, Jasmine Y., et al.
Publicado: (2023)

Effects of FVIII immunity on hepatocyte and hematopoietic stem cell–directed gene therapy of murine hemophilia A
por: Lytle, Allison M, et al.
Publicado: (2016)

Leukemia’s Next Top Model? Syngeneic Models to Advance Adoptive Cellular Therapy
por: Zoine, Jaquelyn T., et al.
Publicado: (2022)

In vivo expansion and activation of γδ T cells as immunotherapy for refractory neuroblastoma: A phase 1 study
por: Pressey, Joseph G., et al.
Publicado: (2016)

The promise of γδ T cells and the γδ T cell receptor for cancer immunotherapy
por: Legut, Mateusz, et al.
Publicado: (2015)

Targeting T cell malignancies using CAR-based immunotherapy: challenges and potential solutions
por: Fleischer, Lauren C., et al.
Publicado: (2019)

γδ T Cells and Their Potential for Immunotherapy
por: Wu, Yan-Ling, et al.
Publicado: (2014)

γδ T cells in cancer immunotherapy
por: Zou, Chang, et al.
Publicado: (2016)

Human γδ T Cell Subsets and Their Clinical Applications for Cancer Immunotherapy
por: Lee, Derek, et al.
Publicado: (2022)

The γδ T Lymphocytes of the Perinatal Murine Thymus
por: Zorbas, Michelle I., et al.
Publicado: (1995)

Stoichiometry of the murine γδ T cell receptor
por: Hayes, Sandra M., et al.
Publicado: (2006)

γδ T Cell Immunotherapy—A Review
por: Kobayashi, Hirohito, et al.
Publicado: (2015)

Cyclophosphamide in combination with tumor lysate and TLR9 ligand regresses murine neuroblastoma
por: Gershan, Jill, et al.
Publicado: (2013)

Monitoring Circulating γδ T Cells in Cancer Patients to Optimize γδ T Cell-Based Immunotherapy
por: Oberg, Hans-Heinrich, et al.
Publicado: (2014)

Engineered Drug Resistant γδ T Cells Kill Glioblastoma Cell Lines during a Chemotherapy Challenge: A Strategy for Combining Chemo- and Immunotherapy
por: Lamb, Lawrence S., et al.
Publicado: (2013)

Control of Murine Cytomegalovirus Infection by γδ T Cells
por: Sell, Sabrina, et al.
Publicado: (2015)

γδ T Cells: The Ideal Tool for Cancer Immunotherapy
por: Yazdanifar, Mahboubeh, et al.
Publicado: (2020)

3D modelling of γδ T‐cell immunotherapy
por: Hull, Caroline M., et al.
Publicado: (2022)

The emerging role of γδ T cells in cancer immunotherapy
por: Nussbaumer, Oliver, et al.
Publicado: (2019)

γδ T cells in immunotherapies for B-cell malignancies
por: Rimailho, Léa, et al.
Publicado: (2023)

Bystander-Mediated Regression of Murine Neuroblastoma via Retroviral Transfer of the HSV-TK Gene
por: Cho, Hyun-Sang, et al.
Publicado: (2004)

Enhancing the pharmaceutical properties of protein drugs by ancestral sequence reconstruction
por: Zakas, Philip M., et al.
Publicado: (2016)

γδTFH cells promote B cell maturation and antibody production in neuroblastoma
por: Mou, Wenjun, et al.
Publicado: (2017)

A New Player in Neuroblastoma: YAP and Its Role in the Neuroblastoma Microenvironment
por: Shim, Jenny, et al.
Publicado: (2021)

Multifunctional γδ T cells and their receptors for targeted anticancer immunotherapy
por: Scheper, Wouter, et al.
Publicado: (2013)

Immunotherapy of acute myeloid leukemia based on γδ T cells
por: Gertner-Dardenne, Julie, et al.
Publicado: (2012)

Cancer Immunotherapy Using γδT Cells: Dealing with Diversity
por: Scheper, Wouter, et al.
Publicado: (2014)

Current Advances in γδ T Cell-Based Tumor Immunotherapy
por: Lo Presti, Elena, et al.
Publicado: (2017)

Γδ T Cell-Based Immunotherapy in Melanoma: State of the Art
por: Toia, F., et al.
Publicado: (2019)

A close look at current γδ T-cell immunotherapy
por: Ma, Ling, et al.
Publicado: (2023)

Biological characteristics of γδT cells and application in tumor immunotherapy
por: Zhu, Renhong, et al.
Publicado: (2023)

γδ T cells: origin and fate, subsets, diseases and immunotherapy
por: Hu, Yi, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_ji25lm72obnjoej54khf4u64po